Saturday, May 10, 2025

Yearly Archives: 2020

CRASH COURSE ON CLINICAL DATA MANAGEMENT

Specially designed Course for Freshers and entry Level Professionals on Clinical Data Management  is going to be held 29 Nov (Sunday) from 10:00 A.M-12:30...

AZ’s Imfinzi approved in the US for less-frequent, fixed-dose use

November 20, 2020: "AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for an additional dosing option, a 1,500mg fixed dose every four weeks, in the...

Novartis secures exclusive rights for potential ARD syndrome cell therapy

November 19, 2020: "Novartis announced today that it entered into an exclusive worldwide license and collaboration agreement with Mesoblast to develop, commercialize and manufacture remestemcel-L...

Sosei Heptares’ COVID-19 programme advances promising molecules

November 20, 2020: "Sosei Group Corporation announces a progress update for its R&D program focused on the design and development of novel drugs targeting...

ViiV Healthcare announces results of the PROgress study for improving HIV care

November 18, 2020: "ViiV Healthcare, with Pfizer Inc. and Shionogi Limited as shareholders announced positive initial findings from the PROgress study, which was...

Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate

November 18, 2020: "Pfizer and BioNTech announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine...

Lead Pharma and Roche enter €260m collaboration agreement for Immune Mediated Diseases

November 16, 2020: Lead Pharma, a clinical stage pharmaceutical company, designing and developing innovative medicines for the treatment of immune mediated diseases and cancer...

Sanofi’s Rilzabrutinib granted FDA Fast Track Designation for thrombocytopenia

November 18, 2020: "The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to the oral investigational Bruton’s tyrosine kinase (BTK) inhibitor,...

£12.2m boost for COVID-19 real-time genomic surveillance system

November 16, 2020: "The Department for Health and Social Care Testing Innovation Fund has backed the Wellcome Sanger Institute and the COVID-19 Genomics UK...

Pfizer completes transaction to combine its upjohn business with Mylan

November 16, 2020: "Pfizer announced that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to...

6,000 volunteers to take part in Janssen phase 3 COVID-19 vaccine trial

November 16-2020: "6,000 UK volunteers will be called upon to take part in a phase 3 trial for the COVID-19 vaccine developed by The...

University of Exeter and MDC combine to industrialise academic medicines research

November 12 2020: The University of Exeter and Medicines Discovery Catapult (MDC) announce their strategic partnership to accelerate medicines Research & Development (R&D), creating value...
- Advertisment -

Most Read